Saint-Gobain Life Sciences acquires France-based MS Techniques and Transluminal
Saint-Gobain Life Sciences is broadening its medical components capabilities with the acquisition of MS Techniques and Transluminal while also establishing a European Medical Center for Excellence.
The 137-person company, located in Pompey near Nancy, France, brings to Saint-Gobain years of experience in high-precision thermoplastic extrusion and design expertise for minimally invasive catheter solutions with a strong focus into the cardiovascular market. The company’s design and manufacturing capabilities will be complemented by Saint-Gobain’s material expertise, financial strength, and global presence in the medical device market.
MS Techniques and Transluminal will be integrated within Saint-Gobain Life Sciences’ Medical Components business unit.
At their core, both companies are very similar, and have customised, co-development models, and similar corporate cultures. Saint-Gobain is building on these synergies to bring customers the very best of both companies.
John Schmitz, General Manager for Saint-Gobain’s Medical Components and Electronics department, said: “We are looking forward to welcoming MS Techniques and Transluminal to the Saint-Gobain Medical family. Aligning with our growth strategy, they strengthen our presence in Europe, broaden our precision extrusion capabilities and catheter design expertise, helping us further expand into the interventional and minimally invasive market.”
Etienne Malher, President MS Techniques, added: “We decided to join forces with Saint-Gobain because we felt we found a true partnership and shared the same vision: to become a world-class reference in the medical device industry for delivering minimally invasive innovation. Joining a global medical organisation with the size and tremendous legacy of Saint-Gobain makes it possible to carry forward what we have worked so hard to build over the last 28 years. With more resources and the Saint-Gobain brand supporting our efforts, we pave the way for future innovation.”